APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,745,629 | -24.9% | 3,542,209 | +79.8% | 0.11% | -22.4% |
| Q2 2023 | $179,521,932 | +4.2% | 1,970,603 | -24.6% | 0.15% | -7.0% |
| Q1 2023 | $172,338,112 | +32.5% | 2,612,767 | +3.9% | 0.16% | +19.7% |
| Q4 2022 | $130,067,043 | -24.9% | 2,515,317 | -0.8% | 0.13% | -23.3% |
| Q3 2022 | $173,121,000 | +66.6% | 2,534,712 | +10.3% | 0.17% | +65.4% |
| Q2 2022 | $103,931,000 | -24.4% | 2,298,347 | -15.0% | 0.10% | +3.0% |
| Q1 2022 | $137,410,000 | +56.1% | 2,704,390 | +45.2% | 0.10% | +80.4% |
| Q4 2021 | $88,043,000 | +28.5% | 1,862,157 | -10.4% | 0.06% | +27.3% |
| Q3 2021 | $68,519,000 | -55.7% | 2,078,845 | -15.1% | 0.04% | -57.3% |
| Q2 2021 | $154,810,000 | +33.1% | 2,449,524 | -9.6% | 0.10% | +21.2% |
| Q1 2021 | $116,324,000 | -26.6% | 2,710,877 | -2.2% | 0.08% | -24.8% |
| Q4 2020 | $158,582,000 | +85.2% | 2,772,420 | -2.3% | 0.11% | +63.8% |
| Q3 2020 | $85,616,000 | +23.2% | 2,837,786 | +33.4% | 0.07% | +9.5% |
| Q2 2020 | $69,470,000 | +24.1% | 2,127,078 | +1.8% | 0.06% | -7.4% |
| Q1 2020 | $55,978,000 | +65.4% | 2,089,517 | +89.1% | 0.07% | +100.0% |
| Q4 2019 | $33,836,000 | +27.9% | 1,105,031 | +0.6% | 0.03% | +21.4% |
| Q3 2019 | $26,459,000 | +13.1% | 1,098,355 | +19.0% | 0.03% | +21.7% |
| Q2 2019 | $23,395,000 | +104.3% | 923,244 | +57.2% | 0.02% | +109.1% |
| Q1 2019 | $11,454,000 | +47.9% | 587,381 | +0.1% | 0.01% | +22.2% |
| Q4 2018 | $7,742,000 | -24.3% | 586,924 | +2.1% | 0.01% | 0.0% |
| Q3 2018 | $10,221,000 | -18.6% | 574,859 | +0.8% | 0.01% | -25.0% |
| Q2 2018 | $12,550,000 | +49.7% | 570,464 | +50.5% | 0.01% | +50.0% |
| Q1 2018 | $8,383,000 | -36.3% | 379,151 | -37.5% | 0.01% | -38.5% |
| Q4 2017 | $13,170,000 | – | 606,925 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |